Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
Unger JM, Qian L, Redman MW, Tavernier SS, Minasian L, Sigal EV, Papadimitrakopoulou VA, Leblanc M, Cleeland CS, Dzingle SA, Summers TJ, Chao H, Madhusudhana S, Villaruz L, Crawford J, Gray JE, Kelly KL, Gandara DR, Bazhenova L, Herbst RS, Gettinger SN, Moinpour CM.
Unger JM, et al. Among authors: crawford j.
J Natl Cancer Inst. 2023 Apr 11;115(4):437-446. doi: 10.1093/jnci/djad003.
J Natl Cancer Inst. 2023.
PMID: 36625510
Free PMC article.
Clinical Trial.